Recombinant SARS Core (aa 1-49) Protein
We can offer labeled proteins/antibodies using a broad range of intensely fluorescent dyes and labels including FITC, Biotin, Alexa Fluor, Rhodamine B, Cy, Co-Au.
Cat: CX3581A
| Species | SARS |
|---|---|
| Source | E. coli |
| Tag | N/A |
| Conjugation | Unonjugated |
| Format | Lyophilized |
| Purity | ≥95% by SDS PAGE |
| Concentration | Please refer to the vial lable for the specific concentration. |
| Purification | Affinity purification |
| Buffer | Supplied in 50mM Tris-HCl, 60mM NaCl and 50% glycerol. Reconstitute the protein with 100 µl of Millipore water. |
| Application | WB; ELISA; Immunogen |
| AA Sequence | aa 1-49 |
| Shipping | The product is shipped at 4 ℃. Upon receipt, store it immediately at the temperature listed below. |
|---|---|
| Storage | Store at ≦ -20℃. Avoid freeze / thaw cycles. |
| Note | For research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. |
| Keywords | SARS |
|---|---|
| Background | SARS is a viral respiratory disease caused by a SARS-coronavirus. While SARS cases were detected as early as November 2002 as part of an outbreak that emerged in China and subsequently spread to 28 other countries, the pathogen causing the disease was identified as a coronavirus at the end of February 2003. |
| Synonyms | SARS Core; Spike Protein; SARS Spike S2; Spike Protein; SARS Spike S2; S2; 2003 S2; SARS S2; SARS-CoV-2 spike RBD; COVID-19 vaccine (aPA-RBD) S; spike protein |
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.